Atrion Corp(ATRI) Finding the best opportunities to buy and sell stocks daily.

Sector:

Healthcare

Description:

Atrion Corp. engages in the manufacture and development of products for medical applications. The company is headquartered in Allen, Texas and currently employs 570 full-time employees. The firm's medical products range from fluid delivery devices to ophthalmic and cardiovascular products. Its fluid delivery products include valves that promote infection control and needle safety. The company has developed a range of valves designed to fill, hold and release controlled amounts of fluids or gasses on demand for use in various intubation, intravenous, catheter and other applications in areas, such as anesthesia and oncology. Its cardiovascular product, MPS2 Myocardial Protection System (MPS2), is the system used in open-heart surgery that delivers fluids and medications, mixes critical drugs and controls temperature, pressure and other variables. The firm manufactures specialized medical devices that disinfect contact lenses. Its other medical and non-medical product lines consist of instrumentation and associated disposables.

Current Price

$604.58

RSI

43.980

Beta:

0.0888

March 31, 2021
0.011 %
$ 6.80
0.567 %
21.610 %
3.5M

-6.450 %
-1.891 %
45.060 %
-6.826 %

$147,591,000
$155,066,000
$152,448,000
$146,595,000
$143,487,000
$145,733,000
-4.821 %
1.717 %
3.993 %
2.166 %
-1.541 %

$38,467,000
$43,168,000
$42,036,000
$42,340,000
$39,266,000
$40,870,000
-10.890 %
2.693 %
-0.718 %
7.829 %
-3.925 %

News

Press Releases

Notable Dates

All stock recommendations and comments are all opinions. Investors should be cautious about any and all stock recommendations and should consider the source of any advice on stock selection. Various factors, including personal ownership, may influence or factor into a stock analysis or opinion. All investors are advised to conduct their own independent research into individual stocks before making a purchase decision. In addition, investors are advised that past stock performance is not indicative of future price action.